INNOVATIVE RESEARCH
The institute provides a world-class interdisciplinary training environment for the preparation of technically skilled students who are capable of filling the diverse workforce needs in biomedical sciences. With key assets including centers for the study of inflammation, immunity and infection, microbial pathogenesis, oncology, molecular and cellular medicine and diagnostics and therapeutics the unit delivers both academic and research value to the field.
We’ve launched a new bachelor’s degree program. The program prepares students for employment in the biomedical industry or advanced degrees in science, business or law. Learn More
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute of Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the Institute each year, and the university is planning even more expansion.
More
Top Stories
Biomedical Sciences Researchers Discover Blocking Key Mineral Uptake Could Prevent Gonorrhea Infection
Blocking the ability of the bacterial pathogen that causes gonorrhea to uptake the mineral zinc can stop infection by this widespread sexually transmitted infection, according to a study by the Institute for Biomedical Sciences at Georgia State University.read more ❯
New Microbiology Review Book is Study Aid for Medical Board Exams and Pre-Med, Medical and Graduate Students
A new review book is designed to make studying easier for students in medical school, graduate microbiology programs or undergraduate pre-med programs and individuals preparing for the United States Medical Licensing Examination (USMLE).read more ❯
Biomedical Sciences Researcher Gets $3.26 Million Grant To Develop Universal Flu Vaccine
Influenza remains a major public health risk, and Dr. Baozhong Wang, associate professor in Georgia State University’s Institute for Biomedical Sciences, has received a five-year, $3.26 million federal grant to combat this threat by developing a universal vaccine that offers more protection against influenza than seasonal vaccines.read more ❯